Harvard Diabetes Professor says artificial pancreas and stem cells will revolutionize treatment

Recent medical developments indicate that the world is approaching a revolution in the treatment of type 1 diabetes through techniques such as the artificial pancreas and stem cell therapy. Currently, the "Nia" device is being developed, which integrates blood sugar measurement and insulin delivery into a small device with remote monitoring via a phone. It is expected to be launched by 2028, enhancing patient comfort and quality of life. Additionally, stem cell research has achieved successes in clinical trials, with some patients able to stop using insulin, supported by the U.S. Food and Drug Administration. Future treatments are heading toward providing more precise and effective technological and biological solutions, with the possibility of transferring these technologies to Egypt thanks to specialized medical personnel. This represents a significant hope for greatly improving the lives of people with diabetes.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article